Proton beam therapy after surgery for parotid cancer
Part of Cancer, Mouth & dental clinical trials.
This trial is testing a precise type of radiation called proton beam therapy for people with parotid gland cancer. It aims to see if this treatment, given after surgery, can reduce side effects while still being effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed cancer in the parotid gland (a saliva gland near your ear).
- You need radiation therapy after surgery, with a dose of at least 60 Gray (a standard radiation dose).
- You have not had radiation to your head or neck before.
- You are not getting chemotherapy as part of your treatment plan.
- You are willing to travel to a proton center for treatment and attend regular follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a type of proton beam treatment can be given safely and effectively to tumors that have already been treated with radiation before. It may help people whose tumors came back or persisted after earlier radiation, using a specific proton method called pencil beam scanning.
This trial studies whether proton radiotherapy can treat primary brain (and sometimes spine) tumors in adults. You may join because your tumor type and situation fit specific diagnoses, including some cases needing a re-treatment plan.
This study tests proton beam radiation aimed at one side of the chest in people with malignant pleural mesothelioma who are not yet having chemotherapy. The goal is to control the cancer while preserving breathing and quality of life for the right patients.
This trial tests a type of precise radiation called proton therapy after surgery for thymus tumors. It may help reduce the chance of the tumor coming back while limiting side effects to nearby organs.
This trial tests a new combination for people whose head and neck cancer has come back after prior radiation. You'll receive an immunotherapy drug (pembrolizumab) plus radiation, then surgery. The goal is to see if this approach can improve how well surgery works.
This trial studies proton radiation therapy for adults with certain benign or slow-growing brain tumors. It aims to see how well tumors can be controlled, and how treatment affects quality of life and side effects.
Hear when a new Parotid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.